LMR Partners’s Guardant Health GH Stock Holding History

LMR Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,100	Closed	-$2.87M	–	1622
2025 Q4	$2.87M	Hold	28,100	–	–	0.01%	726
2025 Q3	$1.76M	Buy	+28,100	New	+$1.53M	0.01%	776

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's GH Position: Q1 2026 in Review

LMR Partners sold out of Guardant Health (GH) in Q1 2026, closing a stake of 16,800 shares — an estimated $1.72M sold.

LMR Partners first reported a position in GH in Q1 2021 and held it in 10 quarters. The position peaked at $14.8M in Q4 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

LMR Partners reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 16,800 Guardant Health shares in Q1 2026, an estimated $1.72M.
LMR Partners first reported a position in Guardant Health in Q1 2021 and held it in 10 quarters.
LMR Partners's Guardant Health position peaked at $14.8M in Q4 2021.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.